Oxytocin Treatment of Opioid Dependence

NCT02548728 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence
Opioid Withdrawal

Interventions

DRUG: Intranasal Oxytocin Spray
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill